<scp>GABA</scp> ameliorates diet‐induced hepatic steatosis and insulin resistance by inhibiting macrophage activation
GABA ameliorates HFD-induced hepatic insulin resistance by suppressing KCs activation and its production and secretion of inflammatory cytokines.
Authors
- Yaqin Ding
- Qinghua Wang (ORCID: https://orcid.org/0000-0002-6478-0988)
- Yijing Liao
- Gérald J. Prud’homme (ORCID: https://orcid.org/0000-0003-3497-5984)
- Bing‐Xing Pan (ORCID: https://orcid.org/0000-0001-6404-4019)
- Wenjuan Du (ORCID: https://orcid.org/0000-0002-0790-9546)
- Qingping Yang (ORCID: https://orcid.org/0000-0002-2557-8752)
- Qiaoli Cui
- Yun Wan (ORCID: https://orcid.org/0000-0001-8128-5180)
- Yiming Li (ORCID: https://orcid.org/0000-0002-1828-8765)
- Ying Zhang (ORCID: https://orcid.org/0000-0002-2563-5606)
- Xiao‐Ming Li (ORCID: https://orcid.org/0000-0002-8617-1702)
- Zhihong Wang (ORCID: https://orcid.org/0000-0002-5836-8073)
- Juan Zheng (ORCID: https://orcid.org/0000-0003-2356-1735)
- Dongdong Jiang (ORCID: https://orcid.org/0000-0002-0737-0990)
- Guang-Yin Xu
Institutions
- Nanchang University (CN)
- Shanxi Medical University (CN)
- University of Toronto (CA)
- Fudan University (CN)
- Soochow University (CN)
- Wuhan Union Hospital (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1111/dom.16556
- Citations
- 3
- Primary Topic
- Biochemical Analysis and Sensing Techniques
- Type
- article
- Field-Weighted Citation Impact
- 3.36
Funders
- National Natural Science Foundation of China